Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Complement C3 and High Risk of Venous Thromboembolism : 80517 Individuals from the Copenhagen General Population Study. / Nørgaard, Ina; Nielsen, Sune Fallgaard; Nordestgaard, Børge Grønne.
I: Clinical Chemistry, Bind 62, Nr. 3, 03.2016, s. 525-534.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Complement C3 and High Risk of Venous Thromboembolism
T2 - 80517 Individuals from the Copenhagen General Population Study
AU - Nørgaard, Ina
AU - Nielsen, Sune Fallgaard
AU - Nordestgaard, Børge Grønne
N1 - © 2015 American Association for Clinical Chemistry.
PY - 2016/3
Y1 - 2016/3
N2 - BACKGROUND: Complement activation may contribute to venous thromboembolism, including deep venous thrombosis and pulmonary embolism. We tested the hypothesis that high complement C3 concentrations are associated with high risk of venous thromboembolism in the general population.METHODS: We included 80 517 individuals without venous thromboembolism from the Copenhagen General Population Study recruited in 2003-2012. Plasma complement C3 concentrations were measured at baseline, and venous thromboembolism (n = 1176) was ascertained through April 2013 in nationwide registries. No individuals were lost to follow-up.RESULTS: Complement C3 concentrations were approximately normally distributed, with a mean value of 1.13 g/L (interquartile range 0.98-1.26; SD 0.21). The cumulative incidence of venous thromboembolism was higher with progressively higher tertiles of complement C3 (log-rank trend: P = 3 × 10(-8)): at age 80, 7%, 9%, and 11% of individuals in the first, second, and third tertiles, respectively, had developed venous thromboembolism. Multivariable-adjusted hazard ratios for venous thromboembolism compared with individuals in the first tertile were 1.36 (95% CI, 1.16-1.59) for those in the second tertile and 1.58 (1.33-1.88) for those in the third tertile. Corresponding values were 1.36 (1.16-1.60) and 1.57 (1.33-1.87) after additional adjustment for C-reactive protein and 1.27 (1.09-1.49) and 1.31(1.10-1.57) after additional adjustment for body mass index. These results were similar for deep venous thrombosis and pulmonary embolism separately. The multivariable-adjusted hazard ratio for venous thromboembolism for a 1-g/L increase in complement C3 was 2.43 (1.74-3.40).CONCLUSIONS: High concentrations of complement C3 were associated with high risk of venous thromboembolism in the general population.
AB - BACKGROUND: Complement activation may contribute to venous thromboembolism, including deep venous thrombosis and pulmonary embolism. We tested the hypothesis that high complement C3 concentrations are associated with high risk of venous thromboembolism in the general population.METHODS: We included 80 517 individuals without venous thromboembolism from the Copenhagen General Population Study recruited in 2003-2012. Plasma complement C3 concentrations were measured at baseline, and venous thromboembolism (n = 1176) was ascertained through April 2013 in nationwide registries. No individuals were lost to follow-up.RESULTS: Complement C3 concentrations were approximately normally distributed, with a mean value of 1.13 g/L (interquartile range 0.98-1.26; SD 0.21). The cumulative incidence of venous thromboembolism was higher with progressively higher tertiles of complement C3 (log-rank trend: P = 3 × 10(-8)): at age 80, 7%, 9%, and 11% of individuals in the first, second, and third tertiles, respectively, had developed venous thromboembolism. Multivariable-adjusted hazard ratios for venous thromboembolism compared with individuals in the first tertile were 1.36 (95% CI, 1.16-1.59) for those in the second tertile and 1.58 (1.33-1.88) for those in the third tertile. Corresponding values were 1.36 (1.16-1.60) and 1.57 (1.33-1.87) after additional adjustment for C-reactive protein and 1.27 (1.09-1.49) and 1.31(1.10-1.57) after additional adjustment for body mass index. These results were similar for deep venous thrombosis and pulmonary embolism separately. The multivariable-adjusted hazard ratio for venous thromboembolism for a 1-g/L increase in complement C3 was 2.43 (1.74-3.40).CONCLUSIONS: High concentrations of complement C3 were associated with high risk of venous thromboembolism in the general population.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Blood Grouping and Crossmatching
KW - Complement C3
KW - Denmark
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Male
KW - Middle Aged
KW - Prospective Studies
KW - Risk Factors
KW - Venous Thromboembolism
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1373/clinchem.2015.251314
DO - 10.1373/clinchem.2015.251314
M3 - Journal article
C2 - 26797686
VL - 62
SP - 525
EP - 534
JO - Clinical Chemistry
JF - Clinical Chemistry
SN - 0009-9147
IS - 3
ER -
ID: 174394012